vs
Dime Community Bancshares, Inc.（DCOM）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Dime Community Bancshares, Inc.的1.7倍（$207.3M vs $123.8M），Dime Community Bancshares, Inc.同比增速更快（3040.1% vs 25.9%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 22.9%）
戴姆社区银行前身是威廉斯堡戴姆储蓄银行，是受FDIC保险的本土银行，1864年创立，最初扎根于纽约布鲁克林威廉斯堡社区，至今在该区域仍保有强劲的市场影响力，目前总部设于纽约州霍波格，2021年已完成与布里奇 Bancorp 的合并。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DCOM vs RARE — 直观对比
营收规模更大
RARE
是对方的1.7倍
$123.8M
营收增速更快
DCOM
高出3014.2%
25.9%
两年增速更快
RARE
近两年复合增速
22.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 38.6% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 3040.1% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.68 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCOMRARE
| Q4 25 | $123.8M | $207.3M | ||
| Q3 25 | $115.6M | $159.9M | ||
| Q2 25 | $109.7M | $166.5M | ||
| Q1 25 | $103.8M | $139.3M | ||
| Q4 24 | $3.9M | $164.6M | ||
| Q3 24 | $87.6M | $139.5M | ||
| Q2 24 | $87.3M | $147.0M | ||
| Q1 24 | $82.0M | $108.8M |
净利润DCOMRARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $27.7M | $-180.4M | ||
| Q2 25 | $29.7M | $-115.0M | ||
| Q1 25 | $21.5M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $13.3M | $-133.5M | ||
| Q2 24 | $18.5M | $-131.6M | ||
| Q1 24 | $17.7M | $-170.7M |
营业利润率DCOMRARE
| Q4 25 | 38.6% | -54.7% | ||
| Q3 25 | 34.7% | -106.9% | ||
| Q2 25 | 36.6% | -64.8% | ||
| Q1 25 | 27.6% | -102.6% | ||
| Q4 24 | -433.6% | -74.3% | ||
| Q3 24 | 20.8% | -94.6% | ||
| Q2 24 | 29.8% | -79.1% | ||
| Q1 24 | 29.6% | -151.9% |
净利率DCOMRARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | 23.9% | -112.8% | ||
| Q2 25 | 27.1% | -69.0% | ||
| Q1 25 | 20.7% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | 15.2% | -95.7% | ||
| Q2 24 | 21.2% | -89.5% | ||
| Q1 24 | 21.6% | -156.8% |
每股收益（稀释后）DCOMRARE
| Q4 25 | $0.68 | $-1.28 | ||
| Q3 25 | $0.59 | $-1.81 | ||
| Q2 25 | $0.64 | $-1.17 | ||
| Q1 25 | $0.45 | $-1.57 | ||
| Q4 24 | $-0.58 | $-1.34 | ||
| Q3 24 | $0.29 | $-1.40 | ||
| Q2 24 | $0.43 | $-1.52 | ||
| Q1 24 | $0.41 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $-80.0M |
| 总资产 | $15.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DCOMRARE
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M | ||
| Q1 24 | — | $112.3M |
股东权益DCOMRARE
| Q4 25 | $1.5B | $-80.0M | ||
| Q3 25 | $1.5B | $9.2M | ||
| Q2 25 | $1.4B | $151.3M | ||
| Q1 25 | $1.4B | $144.2M | ||
| Q4 24 | $1.4B | $255.0M | ||
| Q3 24 | $1.3B | $346.8M | ||
| Q2 24 | $1.3B | $432.4M | ||
| Q1 24 | $1.2B | $140.3M |
总资产DCOMRARE
| Q4 25 | $15.3B | $1.5B | ||
| Q3 25 | $14.5B | $1.2B | ||
| Q2 25 | $14.2B | $1.3B | ||
| Q1 25 | $14.1B | $1.3B | ||
| Q4 24 | $14.4B | $1.5B | ||
| Q3 24 | $13.7B | $1.5B | ||
| Q2 24 | $13.5B | $1.6B | ||
| Q1 24 | $13.5B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $186.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流DCOMRARE
| Q4 25 | $186.6M | $-99.8M | ||
| Q3 25 | $52.1M | $-91.4M | ||
| Q2 25 | $23.1M | $-108.3M | ||
| Q1 25 | $65.4M | $-166.5M | ||
| Q4 24 | $99.1M | $-79.3M | ||
| Q3 24 | $-33.3M | $-67.0M | ||
| Q2 24 | $12.6M | $-77.0M | ||
| Q1 24 | $30.7M | $-190.7M |
自由现金流DCOMRARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $51.2M | $-92.7M | ||
| Q2 25 | $20.4M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | $-34.1M | $-68.6M | ||
| Q2 24 | $9.2M | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率DCOMRARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | 44.3% | -58.0% | ||
| Q2 25 | 18.6% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | -38.9% | -49.2% | ||
| Q2 24 | 10.5% | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度DCOMRARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.7% | 0.8% | ||
| Q2 25 | 2.4% | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 3.9% | 1.4% | ||
| Q1 24 | — | 3.0% |
现金转化率DCOMRARE
| Q4 25 | — | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 3.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.50× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCOM
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
